Rimas V. Lukas

5.0k total citations · 1 hit paper
117 papers, 1.9k citations indexed

About

Rimas V. Lukas is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Rimas V. Lukas has authored 117 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Genetics, 41 papers in Pulmonary and Respiratory Medicine and 40 papers in Oncology. Recurrent topics in Rimas V. Lukas's work include Glioma Diagnosis and Treatment (59 papers), Brain Metastases and Treatment (35 papers) and Lung Cancer Research Studies (17 papers). Rimas V. Lukas is often cited by papers focused on Glioma Diagnosis and Treatment (59 papers), Brain Metastases and Treatment (35 papers) and Lung Cancer Research Studies (17 papers). Rimas V. Lukas collaborates with scholars based in United States, Philippines and Germany. Rimas V. Lukas's co-authors include Craig Horbinski, Tim J. Kruser, Robin Buerki, Peleg Horowitz, C. David James, Roger Stupp, Derek A. Wainwright, M. Kelly Nicholas, Priya Kumthekar and Steven J. Chmura and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and Scientific Reports.

In The Last Decade

Rimas V. Lukas

109 papers receiving 1.9k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An Overview of Meningiomas

2018 308 citations Robin Buerki, Craig Horbinski et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rimas V. Lukas United States	22	790	559	522	435	423	117	1.9k
Émeline Tabouret France	23	1.0k 1.3×	604 1.1×	415 0.8×	282 0.6×	317 0.7×	103	1.8k
Luca Bertero Italy	20	521 0.7×	391 0.7×	451 0.9×	317 0.7×	225 0.5×	130	1.6k
Kevin A. Walter United States	25	752 1.0×	370 0.7×	438 0.8×	252 0.6×	339 0.8×	64	2.1k
Priya Kumthekar United States	24	949 1.2×	831 1.5×	854 1.6×	294 0.7×	248 0.6×	146	2.1k
Laëtitia Padovani France	23	761 1.0×	404 0.7×	463 0.9×	193 0.4×	315 0.7×	86	1.7k
Joohee Sul United States	17	912 1.2×	565 1.0×	491 0.9×	251 0.6×	197 0.5×	26	1.7k
Rohan Ramakrishna United States	27	756 1.0×	370 0.7×	315 0.6×	601 1.4×	370 0.9×	94	1.8k
Robert Olivares France	11	886 1.1×	594 1.1×	574 1.1×	399 0.9×	166 0.4×	21	2.3k
Sean Grimm United States	24	1.2k 1.6×	503 0.9×	416 0.8×	315 0.7×	900 2.1×	79	2.1k
Isabelle Aerts France	28	695 0.9×	646 1.2×	761 1.5×	247 0.6×	564 1.3×	125	2.6k

Countries citing papers authored by Rimas V. Lukas

Since Specialization

Citations

This map shows the geographic impact of Rimas V. Lukas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rimas V. Lukas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rimas V. Lukas more than expected).

Fields of papers citing papers by Rimas V. Lukas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rimas V. Lukas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rimas V. Lukas. The network helps show where Rimas V. Lukas may publish in the future.

Co-authorship network of co-authors of Rimas V. Lukas

This figure shows the co-authorship network connecting the top 25 collaborators of Rimas V. Lukas. A scholar is included among the top collaborators of Rimas V. Lukas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rimas V. Lukas. Rimas V. Lukas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kumthekar, Priya, Rimas V. Lukas, Karan Dixit, et al.. (2024). A qualitative evaluation of factors influencing Tumor Treating fields (TTFields) therapy decision making among brain tumor patients and physicians. BMC Cancer. 24(1). 4 indexed citations

Malhotra, Jyoti, Isa Mambetsariev, Arin Nam, et al.. (2024). Targeting CNS Metastases in Non–Small Cell Lung Cancer With Evolving Approaches Using Molecular Markers. JAMA Oncology. 11(1). 60–60. 2 indexed citations

Zhang, Nigel, Steven C. Hoffman, Maciej S. Lesniak, et al.. (2022). Neurological applications of belzutifan in von Hippel-Lindau disease. Neuro-Oncology. 25(5). 827–838. 10 indexed citations

Fu, Siqing, David Piccioni, Hongtao Liu, et al.. (2021). A phase I study of the WT2725 dosing emulsion in patients with advanced malignancies. Scientific Reports. 11(1). 22355–22355. 13 indexed citations

Stout, Molly J., et al.. (2019). Dermatomyositis in a patient undergoing nivolumab therapy for metastatic melanoma: a case report and review of the literature. Melanoma Research. 30(3). 313–316. 24 indexed citations

Peters, Katherine B., et al.. (2019). Neurooncology Research in Nigeria: Great Untapped Potential. World Neurosurgery. 124. 381–385. 6 indexed citations

Kumthekar, Priya, Karan Dixit, Sean Grimm, et al.. (2019). A phase II trial of bevacizumab in patients with recurrent solid tumor brain metastases who have failed whole brain radiation therapy (WBRT).. Journal of Clinical Oncology. 37(15_suppl). 2070–2070. 5 indexed citations

Ladomersky, Erik, Denise Scholtens, Masha Kocherginsky, et al.. (2019). The Coincidence Between Increasing Age, Immunosuppression, and the Incidence of Patients With Glioblastoma. Frontiers in Pharmacology. 10. 200–200. 86 indexed citations

Lukas, Rimas V., Derek A. Wainwright, Craig Horbinski, Fábio M. Iwamoto, & Adam M. Sonabend. (2019). Immunotherapy Against Gliomas: is the Breakthrough Near?. Drugs. 79(17). 1839–1848. 12 indexed citations

10.

Lukas, Rimas V., Derek A. Wainwright, Erik Ladomersky, et al.. (2019). Newly Diagnosed Glioblastoma: A Review on Clinical Management.. PubMed. 33(3). 91–100. 86 indexed citations

11.

Lukas, Rimas V., Naoum P. Issa, Adil Javed, et al.. (2018). Antiglutamic acid decarboxylase 65 (GAD65) antibody-associated epilepsy. Epilepsy & Behavior. 80. 331–336. 73 indexed citations

12.

Gadgeel, Shirish M., Rimas V. Lukas, Jerome H. Goldschmidt, et al.. (2018). Atezolizumab in patients with advanced non-small cell lung cancer and history of asymptomatic, treated brain metastases: Exploratory analyses of the phase III OAK study. Lung Cancer. 128. 105–112. 132 indexed citations

13.

Ladomersky, Erik, Sebastian Otto‐Meyer, Lijie Zhai, et al.. (2018). IMMU-46. GLIOBLASTOMA PATIENT DIAGNOSES AND IMMUNOSUPPRESSION ARE MAXIMAL DURING OLD AGE: A RANDOM COINCIDENCE, OR CAUSE AND EFFECT?. Neuro-Oncology. 20(suppl_6). vi131–vi131. 1 indexed citations

14.

Fu, Siqing, David Piccioni, Hongtao Liu, et al.. (2017). Initial phase 1 study of WT2725 dosing emulsion in patients with advanced malignancies.. Journal of Clinical Oncology. 35(15_suppl). 2066–2066. 7 indexed citations

15.

Fetcko, Kaleigh, Rimas V. Lukas, Gordon A. Watson, Lingjiao Zhang, & Mahua Dey. (2017). Survival and complications of stereotactic radiosurgery. Medicine. 96(43). e8293–e8293. 35 indexed citations

16.

Lukas, Rimas V., et al.. (2016). Leptomeningeal Carcinomatosis from Pancreatic Cancer Associated With Germline BRCA Mutations: Case Reports and Review of the Literature. JOP, journal of the pancreas. 17(2). 241–246. 3 indexed citations

17.

Albert, Dara V.F., et al.. (2016). Breadth versus volume: Neurology outpatient clinic cases in medical education. Journal of Clinical Neuroscience. 28. 20–23. 5 indexed citations

18.

Lukas, Rimas V. & Maciej M. Mrugała. (2016). Pivotal therapeutic trials for infiltrating gliomas and how they affect clinical practice. Neuro-Oncology Practice. 4(4). 209–219. 25 indexed citations

19.

Lukas, Rimas V., Chao Ma, Hongmei Dong, et al.. (2016). Views on Careers in Clinical Neurosciences Among Neurosurgeons and Neurologists in China. World Neurosurgery. 98. 532–537. 2 indexed citations

20.

Nicholas, M. Kelly, et al.. (2011). Molecular Heterogeneity in Glioblastoma: Therapeutic Opportunities and Challenges. Seminars in Oncology. 38(2). 243–253. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact